Haemonetics Corp
HAE· NYSE
HAEHaemonetics Corp
Filed May 22, 2015 · 10-K · 55 days after period end · 0000313143-15-000033
| Metric | Q4 2015 | Q4 2011 | Q4 2010 | Q4 2009dderived from reported figures |
|---|---|---|---|---|
| Revenue | $226.48M | $186.67M | $170.03M | $169.10M |
| Net Income | -$2.93M | $17.81M | $20.99M | $3.96M |
| EPS Diluted | -$0.06 | $0.35 | $0.81 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
ended Mar 28, 2015 · filed May 22, 2015 · 55 d after period end
